Neuromodulation trials

Neuromodulation and Mindfulness Patients With AUD

RecruitingNCT06308484Phase: NAStarted 2024-03-20

Summary

Our primary objective is to integrate tVNS and mindfulness meditation within a structured mindfulness-based relapse prevention (MBRP) program for detoxified alcohol-dependent patients (AD). We aim to

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
70 Years

Locations

Charité - Berlin University of MedicineBerlin, State of Berlin, Germany

View full study details on ClinicalTrials.gov

clinicaltrials.gov/study/NCT06308484